• Aucun résultat trouvé

PET Imaging of Multiple Myeloma : Comparison of 89Zr- and 64Cu-labeled anti-CD138 Conjugates to 64CuCl2 and 18F-FDG in a Preclinical Syngeneic Model

N/A
N/A
Protected

Academic year: 2021

Partager "PET Imaging of Multiple Myeloma : Comparison of 89Zr- and 64Cu-labeled anti-CD138 Conjugates to 64CuCl2 and 18F-FDG in a Preclinical Syngeneic Model"

Copied!
3
0
0

Texte intégral

(1)

HAL Id: inserm-02341452

https://www.hal.inserm.fr/inserm-02341452

Submitted on 31 Oct 2019

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

PET Imaging of Multiple Myeloma : Comparison of 89Zr- and 64Cu-labeled anti-CD138 Conjugates to 64CuCl2 and 18F-FDG in a Preclinical Syngeneic Model

Clément Bailly, Sébastien Gouard, Benjamin Chalopin, Thomas Carlier, Catherine Sai-Maurel, Patricia Remaud-Le Saec, Mickaël Bourgeois, Nicolas

Chouin, Raphaël Tripier, Ferid Haddad, et al.

To cite this version:

Clément Bailly, Sébastien Gouard, Benjamin Chalopin, Thomas Carlier, Catherine Sai-Maurel, et al..

PET Imaging of Multiple Myeloma : Comparison of 89Zr- and 64Cu-labeled anti-CD138 Conjugates to 64CuCl2 and 18F-FDG in a Preclinical Syngeneic Model. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2018, 45 (1), pp.S20-S21. �inserm-02341452�

(2)
(3)

Références

Documents relatifs

A preclinical syngeneic mouse model, consisting of IV injection of 1 million of 5T33 cells in a KaLwRij C57/BL6 mouse, was treated 10 days later with an anti-mCD138 antibody,

Biodistribu- tion, Imaging and Metabolism Studies of 64-Copper Radiolabelled Monoclonal Antibody : Comparison of DOTA and TE1PA Chelating Agents in a Murine Model of